Duopharma Biotech Bhd
KLSE:DPHARMA
Duopharma Biotech Bhd
Operating Income
Duopharma Biotech Bhd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Operating Income
myr89.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Operating Income
myr4.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Operating Income
myr112.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Operating Income
myr20.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Operating Income
myr39.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Operating Income
myr56.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Operating Income?
Operating Income
89.8m
MYR
Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Operating Income amounts to 89.8m MYR.
What is Duopharma Biotech Bhd's Operating Income growth rate?
Operating Income CAGR 10Y
8%
Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for Duopharma Biotech Bhd have been -1% over the past three years , 2% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet